---
title: 'Leptomeningeal metastatic disease: new frontiers and future directions'
date: '2024-12-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39653782/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241210175343&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Leptomeningeal metastatic disease (LMD), encompassing entities of 'meningeal
  carcinomatosis', neoplastic meningitis' and 'leukaemic/lymphomatous meningitis',
  arises secondary to the metastatic dissemination of cancer cells from extracranial
  and certain intracranial malignancies into the leptomeninges and cerebrospinal fluid.
  The clinical burden of LMD has been increasing secondary to more sensitive diagnostics,
  aggressive local therapies for discrete brain metastases, and improved management
  ...
disable_comments: true
---
Leptomeningeal metastatic disease (LMD), encompassing entities of 'meningeal carcinomatosis', neoplastic meningitis' and 'leukaemic/lymphomatous meningitis', arises secondary to the metastatic dissemination of cancer cells from extracranial and certain intracranial malignancies into the leptomeninges and cerebrospinal fluid. The clinical burden of LMD has been increasing secondary to more sensitive diagnostics, aggressive local therapies for discrete brain metastases, and improved management ...